Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Xtant Medical (NYSE American: XTNT) will release its third-quarter 2025 financial results for the period ended September 30, 2025 before market open on Tuesday, November 11, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical (NYSE American: XTNT) will release its third-quarter 2025 financial results for the period ended September 30, 2025 before market open on Tuesday, November 11, 2025. Sean Browne, President and CEO, and Scott Neils, Chief Financial Officer, will host a conference call at 8:30 AM ET the same day.
Conference dial-in details: 888-506-0062 (U.S.), international 973-528-0011, passcode 579614. A live webcast will be available at https://www.webcaster5.com/Webcast/Page/3039/52972, and a replay will be posted under Investor Info at https://xtantmedical.com/.
Details
News Market Reaction – XTNT
On Nov 4, the day this news came out, XTNT closed 8.55% below the previous close.
Data tracked by StockTitan Argus for the Nov 4 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial officer, will host a conference call at 8:30am ET on that day.
Conference Details:
Conference Date: Tuesday, November 11, 2025
Conference Time: 8:30 AM ET
Conference Dial-in: 888-506-0062
International Dial-in: 973-528-0011
Passcode: 579614
Conference Call Name: Xtant Medical Q3 2025 Financial Results
Webcast link: https://www.webcaster5.com/Webcast/Page/3039/52972
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics serving the chronic and surgical wound care and sports medicine markets, as well as spinal implant systems. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtant-medical-to-announce-third-quarter-2025-financial-results-on-november-11-2025-302603814.html
SOURCE Xtant Medical Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.